Pfizer and Blackstone Agree Up to $1.5 Billion for Obesity Program
Blackstone Life Sciences will provide Pfizer up to $1.5 billion through 2028 to support a clinical program for GLP-1.
Blackstone Life Sciences will provide Pfizer up to $1.5 billion through 2028 to support a clinical program for GLP-1.